Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc. financial statements

Kalaris Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 43.44M10-K
Cash and equivalentsUSD 98.05M10-Q
Total debtUSD 1.45MEODHD

Kalaris Therapeutics, Inc. financials on 6ix · Kalaris Therapeutics, Inc. on 6ix